Masabumi Shibuya Selected Research

Masabumi Shibuya Research Topics

Disease

47	Neoplasms (Cancer) 10/2021 - 03/2002
17	Inflammation (Inflammations) 01/2018 - 03/2002
11	Pathologic Neovascularization 01/2014 - 12/2003
10	Neoplasm Metastasis (Metastasis) 04/2010 - 10/2002
9	Hypoxia (Hypoxemia) 11/2021 - 10/2004
6	Pre-Eclampsia (Preeclampsia) 11/2021 - 11/2009
5	Edema (Dropsy) 01/2016 - 02/2003
4	Starvation 10/2019 - 12/2011
4	Hemorrhage 05/2018 - 02/2003
4	Ischemia 01/2015 - 03/2002
3	Hypertension (High Blood Pressure) 10/2021 - 11/2009
3	Ulcer 03/2019 - 09/2013
3	Bone Diseases (Bone Disease) 01/2018 - 11/2006
3	Breast Neoplasms (Breast Cancer) 01/2016 - 11/2007
3	Wounds and Injuries (Trauma) 01/2016 - 03/2007
3	Hyperplasia 11/2011 - 09/2006
3	Carcinogenesis 07/2011 - 09/2005
3	Ascites 03/2008 - 04/2002
2	Endometriosis 08/2020 - 01/2019
2	Choriocarcinoma 02/2020 - 01/2013
2	Pain (Aches) 01/2020 - 06/2015
2	Fibrosis (Cirrhosis) 09/2019 - 03/2015
2	Stomach Ulcer (Gastric Ulcer) 03/2014 - 09/2013
2	Macular Degeneration (Age-Related Maculopathy) 01/2014 - 06/2013
2	Choroidal Neovascularization 06/2013 - 03/2008
2	Osteosarcoma (Osteogenic Sarcoma) 05/2011 - 05/2009
2	Leukemia 12/2009 - 08/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2009 - 08/2003
2	Glioma (Gliomas) 09/2009 - 09/2008
2	Vascular Remodeling 02/2009 - 09/2003
2	Rheumatoid Arthritis 04/2008 - 09/2006
2	Atherosclerosis 04/2008 - 12/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004 - 09/2002
2	Lung Neoplasms (Lung Cancer) 09/2002 - 08/2002
2	Ovarian Neoplasms (Ovarian Cancer) 06/2002 - 04/2002
1	Cystic Lymphangioma (Hygroma) 11/2021
1	Proteinuria 10/2021
1	Low Back Pain (Lumbago) 01/2020
1	Intervertebral Disc Degeneration 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2019

Drug/Important Bio-Agent (IBA)

55	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020 - 03/2002
23	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2021 - 10/2002
19	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2019 - 03/2002
11	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2020 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2002
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2016 - 06/2002
8	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 09/2003
8	Vascular Endothelial Growth Factor BIBA 01/2016 - 09/2008
6	Tyrosine (L-Tyrosine)FDA Link 11/2021 - 03/2006
6	LigandsIBA 06/2015 - 11/2006
5	Messenger RNA (mRNA)IBA 02/2020 - 12/2011
4	Small Interfering RNA (siRNA)IBA 01/2020 - 12/2011
4	Vascular Endothelial Growth Factor CIBA 01/2016 - 10/2004
4	AntibodiesIBA 07/2011 - 09/2003
3	Phosphotransferases (Kinase)IBA 10/2021 - 09/2006
3	Biological ProductsIBA 01/2018 - 06/2002
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2013 - 03/2006
3	Vascular Endothelial Growth FactorsIBA 01/2013 - 03/2008
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2010 - 08/2003
3	Tyrosine Kinase InhibitorsIBA 03/2008 - 08/2003
3	tivozanibIBA 03/2008 - 09/2006
2	hydrogen sulfite (bisulfite)IBA 11/2021 - 02/2020
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2020 - 11/2018
2	Becaplermin (PDGF-BB)FDA Link 05/2018 - 05/2011
2	Pharmaceutical PreparationsIBA 11/2017 - 11/2009
2	Vascular Endothelial Growth Factor DIBA 01/2016 - 06/2007
2	CytokinesIBA 03/2015 - 05/2009
2	Transcription Factors (Transcription Factor)IBA 03/2015 - 10/2004
2	Acetic Acid (Vinegar)FDA LinkGeneric 03/2014 - 09/2013
2	Neutralizing AntibodiesIBA 03/2014 - 04/2008
2	Histone DemethylasesIBA 05/2013 - 12/2011
2	Blocking AntibodiesIBA 01/2013 - 04/2010
2	AngiopoietinsIBA 12/2011 - 10/2004
2	Complementary DNA (cDNA)IBA 12/2011 - 04/2002
2	Conditioned Culture MediaIBA 06/2011 - 08/2005
2	Placenta Growth FactorIBA 10/2010 - 04/2010
2	Angiogenesis InhibitorsIBA 09/2009 - 06/2005
2	Macrophage Colony-Stimulating FactorIBA 05/2009 - 11/2006
2	beta-hydroxyisovalerylshikoninIBA 02/2009 - 08/2002
2	shikoninIBA 02/2009 - 08/2002
2	HLA-A*02:01 antigenIBA 10/2006 - 06/2005
2	Peptides (Polypeptides)IBA 10/2006 - 06/2005
2	EpitopesIBA 10/2006 - 06/2005
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2004 - 03/2002
2	TIE-2 Receptor (Receptor, TIE 2)IBA 10/2004 - 09/2003
1	Angiogenic ProteinsIBA 11/2021
1	LuciferasesIBA 11/2021
1	AmphiregulinIBA 11/2021
1	A-Form DNA (A-DNA)IBA 02/2020
1	Decitabine FDA Link 02/2020
1	MethyltransferasesIBA 02/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020
1	phosphorylethanolamine (phosphoethanolamine)IBA 10/2019
1	Glutamine (L-Glutamine)FDA Link 10/2019
1	EnzymesIBA 10/2019
1	phosphatidylethanolamineIBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2019

Therapy/Procedure

17	Therapeutics 01/2018 - 05/2004
4	Transplantation 01/2016 - 03/2008
2	Oral Administration 05/2011 - 11/2006